Skip to main content

Featured

5 Things to Know Today – June 9, 2026

  Here are the five stories shaping your money today — from tomorrow's pivotal Bank of Canada decision to a looming trade deadline that could affect every Canadian business. 1. 🏦 Bank of Canada Decides Tomorrow — Hold Expected, But It's Not Simple All eyes are on Ottawa as the Bank of Canada announces its overnight rate decision on Wednesday, June 10 at 9:45 a.m. ET. The benchmark rate currently sits at 2.25%, and a hold is the widely expected outcome. But experts say it's the most uncertain call in months. Canada's economy has slipped into a technical recession — Q1 2026 GDP contracted at an annualized rate of -0.1%, following a downward revision to Q4 2025 (-1.0%). Under normal conditions, that would point toward a rate cut. But with energy-driven inflation climbing to 2.8% in April and geopolitical pressures still unresolved, the Bank is stuck between a rock and a hard place. Governor Tiff Macklem holds a press conference at 10:30 a.m. ET. Markets will be listening ...

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments